| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9396271 | Transplantation Proceedings | 2005 | 4 Pages |
Abstract
Early steroid withdrawal protocol using basiliximab is promising for reducing the incidence of AR (especially steroid-resistant rejection), CMV diseases, and steroid-related complications.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S. Teraoka, S. Sato, M. Sekijima, K. Iwado, Y. Urashima, S. Kudo, K. Kai, I. Koyama, T. Tojinbara, I. Nakajima, S. Fuchinoue,